Related Experiment Video
Updated: Jul 14, 2026

Isolation and Characterization of Neutrophils with Anti-Tumor Properties
Published on: June 19, 2015
Empiric therapy for febrile neutropenia: what are the choices?
1Infectious Diseases Department, Institut Jules Bordet, Bruxelles, Belgium. nathalie.cardinal@bordet.be
Abstract:
The management of febrile neutropenia has evolved gradually over the years toward a risk-adapted strategy based on validated prediction rules by risk of complications. The drug choice for empiric therapy is influenced by several factors, either related to the patient or to the institution. Microbiological distribution of offending pathogens and their pattern of susceptibility to antibiotics are continuously changing. New mechanisms of resistance in both Gram-negative and -positive bacteria have emerged. Guidelines and general statements should always be considered with the local epidemiology.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Urinary Tract Infection IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy